NDC 71610-225

Lorazepam 0.5 mg tablet

On the label: Aphena Pharma Solutions - Tennessee, Inc.. It's repackaged: Aphena Pharma Solutions - Tennessee, Inc. rebottles it from Leading Pharma, LLC's NDC 69315-904.

Where the pills inside were made

Repackaging site

• Aphena Pharma Solutions - Tennessee, LLC, Cookeville, TN, United States · repackages it

Recalls

• Jan 21, 2025 · Class II · The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
  Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
  Lots: Lot #s: N01424, N01425, Exp 03/31/2025; N01659, N01660, Exp 08/31/2025; N01668, 09/2025; N01679, N01704, N01745, Exp 10/31/2025; N01856, Exp 02/28/2026; N01973, Exp 05/31/2026; N02079, Exp 08/31/2026.
• Sep 28, 2017 · Class II · Leading Pharma, LLC
  Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam
  Lots: Lot #E00717

Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.

Product details

Generic drug

Lorazepam: every company that makes it

Form

tablet, oral

Strength

0.5 mg

Approval

ANDA ANDA078203

On the market since

May 16, 2023

Package NDCs

71610-225-10 71610-225-15 71610-225-20 71610-225-28 71610-225-30 71610-225-45 71610-225-53 71610-225-60 71610-225-70 71610-225-75 71610-225-80

Official label

DailyMed (National Library of Medicine), updated Apr 12, 2024

Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?